Sonoma Pharmaceuticals Inc.

SNOA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.25

-$0.03 (-2.34%)

At close: Sep 21, 2026, 4:00 PM ET

$1.31

+$0.06 (+4.45%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.34%

(1D)

Rating

Updated: Aug 15, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $2.1M

1D Range

1.25 1.28

52W Range

0.85 4.60

Valuation (TTM)

PE -1.02

PB 0.32

EV/EBITDA 1.57

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target N/A

Cash Flow

FCF Yield -102.2%

SBC Adj. FCF Yield -114.4%

SBC Impact -11.9%

Margins

Gross Margin 38.9%

Operating Margin -6.4%

FCF Margin -9.8%

Growth (CAGR)

Revenue 3Y | 5Y 19.9% | 5.8%

Dil EPS 3Y | 5Y 81.1% | 51.1%

FCF 3Y | 5Y -24.1% | 33.2%

Returns

ROA -12.5%

ROE -53.6%

ROIC -9.8%

Financial Health

Net Cash

$4.6M

Current Ratio 2.99

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, includin...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 10

IPO Date Jan 24, 2007

Website www.sonomapharma.com

Fiscal Year April - March

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 16, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞